Probability of achieving treatments goals with twice-weekly teriparatide followed by bisphosphonate in Japanese postmenopausal osteoporosis
Journal of Bone and Mineral Metabolism · 2025
DOI: 10.1007/s00774-025-01626-7 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Bone and Mineral Metabolism, 2025. Verfasst von Junichi Takada und 5 weiteren Autor:innen. Beteiligte Einrichtung: Osteoporosis Center, Sapporo Maruyama Orthopaedic Hospital, 1-3, N-7, W-27, Chuo-Ku, Sapporo, Hokkaido, 060-0007, Japan. osteoporosis-center@hokkaido…. Hauptthemen laut MEDLINE: Teriparatide, Osteoporosis, Postmenopausal, Diphosphonates, Bone Density Conservation Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: The purpose of this study is to evaluate the increase in bone mineral density (BMD) and achievement of treatment goals based on the ASBMR/BHOF position statement over 3 years of sequential therapy with 2 years of twice-weekly teriparatide (2/W TPTD) followed by 1 year of bisphosphonate (BP) therapy. MATERIALS AND METHODS: This was a multicenter, retrospective study. Thirty-eight postmenopausal patients with primary osteoporosis at very high risk of fracture according to the Diagnostic Criteria for Primary Osteoporosis in Japan were enrolled. Changes in BMD at the lumbar spine (LS) and total hip (TH) were evaluated. Patients were divided into the naïve group (no history of osteoporosis treatment) and the pre-BP group (prior BP treatment). The treatment goals were assessed using the BMD T-score as follows; Baseline T-score ≤ - 2.5: Greater than - 2.5 at 3 years and baseline T-score > - 2.5: Increase at least 0.5 for LS and 0.2 for TH. RESULTS: The naïve group showed a significant increase in LS-BMD and TH-BMD of 14.6% and 4.8%, respectively, and the pre-BP group only showed a significant increase in LS-BMD of 8.4% over 3 years. In the naïve group, 60.7% (17/28) achieved the treatment goal for LS-BMD, and 39.3% (11/28) achieved for TH-BMD. In the pre-BP group, 50.0% (4/8) achieved the treatment goal for LS-BMD, but no patient achieved the goal for TH-BMD. CONCLUSION: After 3 years of sequential therapy from 2/W TPTD to BP, 50% or more of the patients achieved the treatment goal in the LS-BMD but not in the TH-BMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Osteoporosis Center, Sapporo Maruyama Orthopaedic Hospital, 1-3, N-7, W-27, Chuo-Ku, Sapporo, Hokkaido, 060-0007, Japan. osteoporosis-center@hokkaido.med.or.jp.
- Sapporo Bone and Hand Surgery Institute, Sapporo Minami Orthopaedic Hospital, Sapporo, Hokkaido, Japan.
- Osteoporosis Center, Sapporo Maruyama Orthopaedic Hospital, 1-3, N-7, W-27, Chuo-Ku, Sapporo, Hokkaido, 060-0007, Japan.
- Department of Orthopaedic Surgery, School of Medicine, Sapporo Medical University, Sapporo, Hokkaido, Japan.
- Sapporo Kotoni Orthopaedic, Sapporo, Hokkaido, Japan.
Zitieren
APA
Takada, J., Iba, K., Takebayashi, T., Hanaka, M., Akatsuka, T., & Teramoto, A. (2025). Probability of achieving treatments goals with twice-weekly teriparatide followed by bisphosphonate in Japanese postmenopausal osteoporosis. Journal of Bone and Mineral Metabolism. https://doi.org/10.1007/s00774-025-01626-7
Vancouver
Takada J, Iba K, Takebayashi T, Hanaka M, Akatsuka T, Teramoto A. Probability of achieving treatments goals with twice-weekly teriparatide followed by bisphosphonate in Japanese postmenopausal osteoporosis. Journal of Bone and Mineral Metabolism. 2025. doi:10.1007/s00774-025-01626-7
BibTeX
@article{Takada2025,
author = {Takada, Junichi and Iba, Kousuke and Takebayashi, Tsuneo and Hanaka, Megumi and Akatsuka, Tomohiro and Teramoto, Atsushi},
title = {Probability of achieving treatments goals with twice-weekly teriparatide followed by bisphosphonate in Japanese postmenopausal osteoporosis},
journal = {Journal of Bone and Mineral Metabolism},
year = {2025},
doi = {10.1007/s00774-025-01626-7}
}
EUVIMED